Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data
Abstract Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression prediction, lev...
Similar Items
3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
by: Nevin John, et al.
Published: (2024-08-01)
by: Nevin John, et al.
Published: (2024-08-01)
3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis
by: Nevin John, et al.
Published: (2024-08-01)
by: Nevin John, et al.
Published: (2024-08-01)
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
by: Vicki E Maltby, et al.
Published: (2021-10-01)
by: Vicki E Maltby, et al.
Published: (2021-10-01)
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
by: Helmut Butzkueven, et al.
Published: (2024-01-01)
by: Helmut Butzkueven, et al.
Published: (2024-01-01)
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
by: Edward De Brouwer, et al.
Published: (2024-07-01)
by: Edward De Brouwer, et al.
Published: (2024-07-01)
Accessible Ecosystem for Clinical Research (Federated Learning for Everyone): Development and Usability Study
by: Ashkan Pirmani, et al.
Published: (2024-07-01)
by: Ashkan Pirmani, et al.
Published: (2024-07-01)
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study
by: David Levitz, et al.
Published: (2024-11-01)
by: David Levitz, et al.
Published: (2024-11-01)
3149 Real-world Australian experience with Ofatumumab in the MSBase registry
by: Nevin John, et al.
Published: (2024-08-01)
by: Nevin John, et al.
Published: (2024-08-01)
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
by: Simona Toscano, et al.
Published: (2025-03-01)
by: Simona Toscano, et al.
Published: (2025-03-01)
2 The clinical relevance of MOG antibody testing in cerebrospinal fluid versus serum
by: David Brown, et al.
Published: (2024-08-01)
by: David Brown, et al.
Published: (2024-08-01)
3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis
by: Tomas Kalincik, et al.
Published: (2024-08-01)
by: Tomas Kalincik, et al.
Published: (2024-08-01)
3116 Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
by: Tomas Kalincik, et al.
Published: (2024-08-01)
by: Tomas Kalincik, et al.
Published: (2024-08-01)
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis
by: Yi Chao Foong, et al.
Published: (2025-04-01)
by: Yi Chao Foong, et al.
Published: (2025-04-01)
3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic
by: Nevin John, et al.
Published: (2024-08-01)
by: Nevin John, et al.
Published: (2024-08-01)
Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
by: Sinali O. Seneviratne, et al.
Published: (2022-03-01)
by: Sinali O. Seneviratne, et al.
Published: (2022-03-01)
Catching the bad apples to keep up the good work: Dutch municipal government perspectives on data-driven technologies in unemployment
by: Margot Kersing, et al.
Published: (2025-01-01)
by: Margot Kersing, et al.
Published: (2025-01-01)
From Dusty Shelves to Dynamic Spaces
by: David Oldenhof
Published: (2023-07-01)
by: David Oldenhof
Published: (2023-07-01)
APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
by: E Losonczi, et al.
Published: (2010-11-01)
by: E Losonczi, et al.
Published: (2010-11-01)
Computables
by: María Pía Cartechini
Published: (2024-09-01)
by: María Pía Cartechini
Published: (2024-09-01)
The clinical relevance of MOG antibody testing in cerebrospinal fluid
by: Molly Reynolds, et al.
Published: (2024-09-01)
by: Molly Reynolds, et al.
Published: (2024-09-01)
Modelling the fate of surface melt on the Larsen C Ice Shelf
by: S. Buzzard, et al.
Published: (2018-11-01)
by: S. Buzzard, et al.
Published: (2018-11-01)
Native English teachers (NETs) strategies in teaching English to non-native learners
by: Pebrina Pirmani, et al.
Published: (2023-08-01)
by: Pebrina Pirmani, et al.
Published: (2023-08-01)
3218 Biomarkers of neurodegeneration as diagnostic and prognostic markers in autoimmune encephalitis
by: Helmut Butzkueven, et al.
Published: (2024-08-01)
by: Helmut Butzkueven, et al.
Published: (2024-08-01)
3222 Does location matter? An exploration of autoimmune encephalitis in the rural and regional setting
by: Helmut Butzkueven, et al.
Published: (2024-08-01)
by: Helmut Butzkueven, et al.
Published: (2024-08-01)
Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset
by: Jan Yperman, et al.
Published: (2022-05-01)
by: Jan Yperman, et al.
Published: (2022-05-01)
La contribution du droit à la gouvernance territoriale : le cas du projet de parc national Tursujuq
by: Sébastien Grammond, et al.
Published: (2012-04-01)
by: Sébastien Grammond, et al.
Published: (2012-04-01)
Zastosowanie zasady uzasadnionych oczekiwań w podatku od towarów i usług: studium przypadku
by: Beata Rogowska-Rajda
Published: (2023-12-01)
by: Beata Rogowska-Rajda
Published: (2023-12-01)
INTERNET LAW TRENDS IN EUROPE: A CASE LAW PERSPECTIVE - 10.12818/P.0304-2340.2017vBIp305
by: Nicola Lugaresi
Published: (2017-08-01)
by: Nicola Lugaresi
Published: (2017-08-01)
INTERNET LAW TRENDS IN EUROPE: A CASE LAW PERSPECTIVE - 10.12818/P.0304-2340.2017vBIp305
by: Nicola Lugaresi
Published: (2017-08-01)
by: Nicola Lugaresi
Published: (2017-08-01)
INTERNET LAW TRENDS IN EUROPE: A CASE LAW PERSPECTIVE - 10.12818/P.0304-2340.2017vBIp305
by: Nicola Lugaresi
Published: (2017-08-01)
by: Nicola Lugaresi
Published: (2017-08-01)
Preserved auditory-motor synchronization during finger-tapping to music and metronomes at various tempi in progressive multiple sclerosis
by: Nele Vanbilsen, et al.
Published: (2025-05-01)
by: Nele Vanbilsen, et al.
Published: (2025-05-01)
SENTIDOS, TENSIONES Y DISPUTAS EN LA DOCENCIA SECUNDARIA RURAL DURANTE LA PANDEMIA: EL CASO DE LA PROVINCIA DE MENDOZA (ARGENTINA) EN EL PERÍODO 2020-2022
by: Alejandro Vassiliades, et al.
Published: (2025-09-01)
by: Alejandro Vassiliades, et al.
Published: (2025-09-01)
Desafios do aprender a ensinar História: reflexões sobre o livro didático a partir do Projeto Pibid (Fahist)
by: Erinaldo Cavalcanti, et al.
Published: (2021-01-01)
by: Erinaldo Cavalcanti, et al.
Published: (2021-01-01)
Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective study
by: Tomas Kalincik, et al.
Published: (2024-08-01)
by: Tomas Kalincik, et al.
Published: (2024-08-01)
Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort
by: Zsófia Hayden, et al.
Published: (2021-03-01)
by: Zsófia Hayden, et al.
Published: (2021-03-01)
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.
by: Claire Meyniel, et al.
Published: (2012-01-01)
by: Claire Meyniel, et al.
Published: (2012-01-01)
Catholicism and pan-European identity from Schuman to Orbán
by: Mark Cauchi
Published: (2023-05-01)
by: Mark Cauchi
Published: (2023-05-01)
Every Wholly Other: Postsecular Pluralism in Isabel Rocamora's Faith
by: Mark Cauchi
Published: (2024-06-01)
by: Mark Cauchi
Published: (2024-06-01)
Self-creation of Older People in the Perspective of Developing Wisdom and Adaptation to Changing Roles in the Family and Society
by: Jakub Fabiś
Published: (2024-10-01)
by: Jakub Fabiś
Published: (2024-10-01)
Assessing the Suitability of DME for Powering SI Engines by Analyzing In-Cylinder Pressure Change
by: Paweł Fabiś
Published: (2022-06-01)
by: Paweł Fabiś
Published: (2022-06-01)
Similar Items
-
3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
by: Nevin John, et al.
Published: (2024-08-01) -
3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis
by: Nevin John, et al.
Published: (2024-08-01) -
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
by: Vicki E Maltby, et al.
Published: (2021-10-01) -
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
by: Helmut Butzkueven, et al.
Published: (2024-01-01) -
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
by: Edward De Brouwer, et al.
Published: (2024-07-01)
